Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor

Leukemia, Monocytic, Acute Clinical Trial

Official title:

Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00531583
• Other study ID #: RAC#2001-004
• Status: Completed
• Phase: N/A
• First received: September 17, 2007
• Last updated: January 4, 2016
• Start date: March 2001
• Est. completion date: June 2015

Study information

• Verified date: January 2016
• Source: King Faisal Specialist Hospital & Research Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: ORA: KFSH&RC, Riyadh, Saudi Arabia
• Study type: Interventional

Clinical Trial Summary

Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantation program for pts w/AML in 1st & 2nd complete remission w/no HLA matched related donor

Recruitment information / eligibility

• Status: Completed
• Enrollment: 350
• Est. completion date: June 2015
• Est. primary completion date: June 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Patients with AML in 1st & 2nd complete remission w/no HLA matched related donor

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Leukemia, Monocytic, Acute

Intervention

Drug:
• Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantation
Autologous PBSCT

Locations

Country	Name	City	State
Saudi Arabia	KFSH&RC	Riyadh

Sponsors (1)

Lead Sponsor	Collaborator
King Faisal Specialist Hospital & Research Center

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Efficacy		2009-2015	No